Jennifer Roth
About Jennifer Roth
Jennifer Roth is the Director of PRISM at the Broad Institute of MIT and Harvard, where she has worked in various capacities since 2014. She has extensive expertise in oncology and immunology drug development and is recognized for her strong interpersonal and communication skills.
Current Role at Broad Institute
Jennifer Roth serves as the Director of PRISM at the Broad Institute of MIT and Harvard. She has held this position since 2021, contributing to the institute's mission in advancing biomedical research. In addition to her directorial role, she has been involved in various capacities at the Broad Institute since 2014, including her current role as Associate Director of PRISM, which she has held since 2018.
Previous Experience at Broad Institute
Prior to her current role, Jennifer Roth worked at the Broad Institute in several positions. She served as a Supervisor for PRISM Cell Operations for six months in 2016 and as a Manager for the PRISM Cell Team from 2017 to 2018. Additionally, she was a Research Associate from 2014 to 2016. Her tenure at the Broad Institute has spanned multiple roles, reflecting her growth and expertise in the organization.
Professional Background
Jennifer Roth has a diverse professional background in the pharmaceutical and biotechnology sectors. She worked as a Research Associate at Merck from 2005 to 2008 and as a Senior Research Analyst at Fuld & Company from 2008 to 2009. Earlier in her career, she was an Associate Scientist at Pfizer Inc. from 1997 to 2002. This extensive experience has equipped her with a strong foundation in drug development and research.
Educational Qualifications
Jennifer Roth holds an MBA from the Questrom School of Business at Boston University, which she completed from 2006 to 2009. She also earned a Bachelor of Science in Biochemistry from the University of New Hampshire from 1992 to 1996. Additionally, she studied Biology at Brown University, where she achieved an AM degree. Her educational background supports her expertise in oncology and immunology.
Expertise and Skills
Jennifer Roth has extensive expertise in oncology and immunology drug development. She conducts primary and secondary competitive intelligence research and strategic analysis for major pharmaceutical and biotech companies. Her recognized interpersonal and communication skills, along with her proactive work ethic, contribute to her effectiveness as a team player in collaborative research environments.